GlassScriptPhysician profile
Elina Trofimovsky
NPI 1720303258
$2,835.81
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,307 · 2020: $418 · 2021: $11.19 · 2022: $44.30 · 2024: $55.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $312.30 | 2019-2020 | |
| Novo Nordisk INC | $286.59 | 2019-2020 | |
| Amgen INC. | $276.96 | 2019-2020 | |
| Corcept Therapeutics | $248.90 | 2019 | |
| Sanofi-Aventis U.S. LLC | $203.42 | 2019-2020 | |
| Ibsa Pharma INC. | $162.35 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.46 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $128.53 | 2019-2020 | |
| Insulet Corporation | $117.07 | 2019-2020 | |
| Pfizer INC. | $108.98 | 2019-2020 | |
| Radius Health, INC. | $94.24 | 2019 | |
| Eisai INC. | $83.12 | 2019 | |
| Janssen Pharmaceuticals, INC | $81.03 | 2019-2020 | |
| Medtronic Minimed, INC. | $62.67 | 2019-2020 | |
| Amarin Pharma, INC. | $58.66 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $55.49 | 2021-2022 | |
| Amphastar Pharmaceuticals, INC. | $55.23 | 2024 | |
| Merck Sharp & Dohme LLC | $54.86 | 2019-2020 | |
| Aytu Biopharma, INC. | $51.80 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $39.02 | 2019 | |
| Currax Pharmaceuticals LLC | $33.07 | 2019-2020 | |
| Shire North American Group INC | $32.98 | 2019 | |
| Abbvie INC. | $32.96 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $29.62 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $21.00 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.17 | 2020 | |
| Vivus LLC | $15.80 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $13.53 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elina Trofimovsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.